Related Experiment Videos
Large-cell lymphoma. An unusual late relapse
K M Bowles1, R Tooze, R E Marcus
1Department of Haematology, Addenbrookes Hospital, Cambridge, UK.
Clinical and Laboratory Haematology
|September 13, 2001
Summary
A man initially diagnosed with liposarcoma was found to have anaplastic large-cell lymphoma. He achieved complete remission after anthracycline chemotherapy, high-dose chemotherapy, and stem-cell transplantation.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- A 40-year-old male presented with advanced anaplastic large-cell lymphoma (ALCL).
- Previous diagnosis of liposarcoma 13 years prior, treated with anthracycline-containing chemotherapy.
Observation:
- Histopathological review revised the initial liposarcoma diagnosis to ALCL.
- A MUGA scan revealed a reduced ejection fraction of 46%.
Findings:
- The patient achieved initial response to anthracycline-based chemotherapy without further cardiac compromise.
- Successful treatment with high-dose chemotherapy and peripheral blood stem-cell transplantation.
Implications:
- This case highlights the importance of histopathological review for accurate cancer diagnosis.
- Demonstrates successful management of relapsed ALCL with preserved cardiac function.
- Suggests potential for curative treatment in relapsed/refractory ALCL cases.